Babcock & Wilcox Enterprises (BW) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 revenue was $233.6M, down year-over-year due to strategic reduction in low-margin projects and completion of a large 2023 project.
Operating income rose to $42.2M from $12.4M in Q2 2023, driven by a $40.2M gain on the sale of a Denmark-based subsidiary and lower SG&A expenses.
Net income attributable to stockholders was $25.3M, compared to a net loss of $5.1M in Q2 2023.
Adjusted EBITDA for Q2 2024 was $23.3M ($24.6M excluding BrightLoop and ClimateBright), ahead of expectations but down from $26.1M in Q2 2023.
Achieved $25M in annualized cost savings from strategic realignment, progressing toward $30M+ target.
Financial highlights
Q2 2024 consolidated revenues were $233.6M; net income was $25.4M; EPS was $0.24, compared to a loss per share of $0.10 in Q2 2023.
Operating cash flow for the first half of 2024 was $(26.6)M, reflecting the impact of the Denmark subsidiary sale and working capital changes.
Cash and equivalents at June 30, 2024, were $202.1M; total debt was $476.8M; preferred stock outstanding: $191.7M.
Adjusted EBITDA margin for Q2 2024 was 10% (up from 9% in Q2 2023).
Backlog and implied backlog at Q2 end were $472M and $757.8M, respectively, up significantly year-over-year.
Outlook and guidance
Full-year 2024 adjusted EBITDA guidance reiterated at $105M–$115M, excluding BrightLoop and ClimateBright.
Management expects liquidity actions, cost savings, and asset sales to provide sufficient funding for the next 12 months.
Anticipates $10–$15M in 2024 spending on BrightLoop technology and projects.
Expects continued strong bookings and financial performance in the second half of 2024, with a healthy $9B project pipeline.
Additional non-strategic asset sales expected to further improve cash, liquidity, and leverage.
Latest events from Babcock & Wilcox Enterprises
- Backlog jumped 470% to $2.8B on a $2.4B AI data center deal, with EBITDA and guidance up.BW
Q4 202516 Mar 2026 - Adjusted EBITDA rose to $22.3M as asset sales and cost savings improved margins.BW
Q3 202414 Jan 2026 - Q4 growth, record bookings, and higher EBITDA offset by persistent debt and risk factors.BW
Q4 202424 Dec 2025 - Shelf registration allows up to $600M in flexible offerings for growth and clean energy initiatives.BW
Registration Filing16 Dec 2025 - Proxy seeks board declassification, governance reforms, and highlights ESG and pay-for-performance.BW
Proxy Filing1 Dec 2025 - Shareholders will vote on board declassification, governance reforms, and executive pay alignment.BW
Proxy Filing1 Dec 2025 - Key votes on board declassification, director terms, and shareholder rights set for June 2025.BW
Proxy Filing1 Dec 2025 - Record backlog and improved EBITDA, but going concern risks persist amid debt and asset sales.BW
Q1 202525 Nov 2025 - Backlog rose 49% and margins improved as AI-driven demand fueled strong Q2 results.BW
Q2 202523 Nov 2025